Jump to Navigation

We are excited to present
12 abstracts highlighting new
clinical data on FoundationOne Heme

at the 56th American Society of Hematology (ASH) Annual Meeting. Click below to view the schedule.

Hundreds of cancer-related genes.

Multiple alterations.

And a fully informative genomic profile for solid tumors that reveals exactly which ones to focus on.
FoundationOne™

Learn More

Interactive Cancer Explorer

Access all of your patient reports on one secure online portal.

Learn More

Did you know

that more than 30% NSCLC patients with ALK fusions may have tested negatively for ALK by FISH*?

Learn more about the importance of comprehensive genomic profiling in lung cancer.

Every Cancer is Unique

Learn more about how FoundationOne can
help tailor your treatment options.

What is FoundationOne?

FoundationOne is a fully informative genomic profile that helps physicians make treatment decisions for patients with cancer by identifying the molecular growth drivers of their cancers and helping oncologists match them with relevant targeted therapeutic options.

Watch Now
 
Cancer and Treatment Options

Discover more about cancer and learn about available treatment options.

Watch Now
 
Featured Publications

View a list of our published and presented studies.

Read Now
 
 
Order a Test

Order Now

If you are a physician, there are a few ways to get started using FoundationOne (for solid tumors) or FoundationOne Heme (for hematologic malignancies, sarcomas and pediatric cancers) in your clinical practice.

If you are a patient, contact us for more information so you can talk with your doctor to see if FoundationOne or FoundationOne Heme is right for you.